Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for STZ and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for STZ and 80,000+ other tickers.
See exactly how STZ's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for STZ and 80,000+ other tickers.
Constellation Brands, Inc., together with its subsidiaries, produces, imports, markets, and sells beer, wine, and spirits in the United States, Canada, Mexico, New Zealand, and Italy. The company offers beer under the Corona Extra, Corona Familiar, Corona Hard Seltzer, Corona Light, Corona Non-Alcoholic, Corona Premier, Corona Refresca, Modelo Especial, Modelo Chelada, Modelo Negra, Modelo Oro, Victoria, Vicky Chamoy, and Pacifico brands. It also offers wine under the Cook’s California Champagne, Kim Crawford, Meiomi, Mount Veeder, Ruffino, SIMI, My Favorite Neighbor, Robert Mondavi Winery…
STZ is priced for disappointment, even though its core beer franchise remains a heavyweight. Constellation's beer portfolio was the overall top share gainer in the U.S. beer market last quarter.
STZ's premium strategy, strong beer portfolio and brand investments position it for market share gains and long-term growth.
One of the most closely watched investment firms in the world, Berkshire Hathaway, is back in the news, releasing its latest round of portfolio updates.
Just when U.S. alcohol makers were hoping to regain access to Canada, President Donald Trump‘s latest tariffs have revived a trade dispute that has already battered one of the industry's biggest export markets.
Constellation Brands remains a Buy, with valuation reflecting a solid margin of safety amid persistent macro headwinds and resilient brand performance. STZ reported strong Q1 FY27 results, beating estimates, growing beer business market share, and generating $485M in free cash flow, supporting buybacks and dividends. Guidance for FY27 is largely unchanged, projecting $1.6–$1.7B in free cash flow on ~$800M CAPEX, despite elevated marketing spend and ongoing consumer uncertainty.